Summary
A total of 99 paediatric patients (57 male, 42 female) aged 1 to 12 years, weighing 10 to 40kg and with acute pharyngo-amygdalitis were enrolled in a single-blind study to assess the efficacy and tolerability of nimesulide in comparison with naproxen when both drugs were administered over an 8-day treatment period.
Among the 2 treatment groups comprising 99 evaluable patients, demographic analysis of age, weight and height did not reveal statistically significant differences.
Evaluation of fever, pain, inflammation and nasal obstruction over the 8-day treatment period showed a significant improvement in these parameters for those patients treated with nimesulide when compared with naproxen from day 1, with remission of symptoms starting from day 3. These findings were complemented by a superior tolerability profile reported for nimesulide-treated patients.
In conclusion, nimesulide appears to be a safe and effective treatment for paediatric patients with pharyngo-amygdalitis and it has shown superior efficacy and tolerability when compared with naproxen.
Similar content being viewed by others
References
Cadeddu L. Comparison of nimesulide and flurbiprofen in the treatment of non-infectious acute inflammation of the upper respiratory tract. Journal of International Medical Research 16: 466, 1988
Carr DP. Comparison of the systematic inhibition of thromboxane synthesis, antiinflammatory activity and gastrointestinal toxicity of non-steroidal antiinflammatory drugs in the rat. Agents and Actions 19: 374–375, 1986
Catti A. Nimesulide suspension dose finding in children with fever due to upper respiratory tract inflammatory disease. Abstracts from Proceedings of the 18th International Congress of Paediatrics, Honolulu, 1986
Craig KD, Prkachin KM. Nonverbal measures of pain. In Melzack (Ed.) Pain measurement and assessment, pp. 173–179, Raven Press, New York, 1983
Facino RM, Carini M, Brambilla A, Casciarri I, Scaricabarozzi I, et al. Metabolism of nimesulide in man and radical scavenging activity of its main metabolites. 3rd World Conference on Inflammation, Monte Carlo (Monaco), March, 1989
Ferreti M, Zollo C. La nimesulide nel trattamento delle flogosi in otorinolaringolatria. Oto-Rino-Laringologia Italiana 37: 363–368, 1987
Lecomte J. Antipyretic effects of nimesulide in paediatric practice: a double blind study. Current Medical Research and Opinion 12: 296, 1991
Milvio C. Nimesulide in elderly patients, activity and evaluation in the treatment of upper respiratory tract disease. 3rd World Congress on Inflammation, Monte Carlo (Monaco), March, 1989
Nouri EM. Nimesulide for treatment of acute inflammation of the upper respiratory tract. Clinical Therapy 6: 142, 1984
Rufer C. Mode of action of antiinflammatory menthanesulphonalides. Biochemical Pharmacology 31: 3591–3596, 1982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Salmòn Rodriguez, L.E., Arista Viveros, H.A., Lujan, M.E. et al. Assessment of the Efficacy and Safety of Nimesulide vs Naproxen in Paediatric Patients with Respiratory Tract Infections. Drugs 46 (Suppl 1), 226–230 (1993). https://doi.org/10.2165/00003495-199300461-00058
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199300461-00058